Oncology Board Review: Blueprint Study Guide and Q&A

Description

Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive print + digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions, detailed rationales, and a convenient print + digital package, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time! Key Features: Aligns with the latest ABIM Medical Oncology Certification Exam blueprint Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam Revised to include new treatment recommendations and FDA approvals Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout Content available digitally via ExamPrepConnect for study on the go ExamPrepConnect Features: All the high-quality content from the book Personalized study plan based on initial certification or MOC exam date Ability to study by topic area to identify strengths and weaknesses Timed practice test that simulates the test-taking environment Discussion board to connect with Medical Oncology exam-prep community Cover Title Copyright Contents Contributors Preface Acknowledgments Part I: Hematologic Malignancies Chapter 1: Acute Myelogenous Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Hairy Cell Leukemia Chapter 2: Chronic Lymphocytic Leukemia Epidemiology Signs and Symptoms Diagnostic Criteria Staging Prognostic Factors Indications for Treatment Treatment Special Considerations Hairy Cell Leukemia Questions Answers Chapter 3: Chronic Myelogenous Leukemia and Myeloproliferative Neoplasms Chronic Myelogenous Leukemia Polycythemia Vera Essential Thrombocythemia Primary Myelofibrosis Chapter 4: Myelodysplastic Syndrome Epidemiology Etiology and Risk Factors Classification Signs and Symptoms Diagnostic Criteria Prognostic Factors Indications for Treatment Treatment Special Considerations Questions Answers Chapter 5: Hodgkin Lymphoma Epidemiology Etiology and Risk Factors Staging Signs and Symptoms Diagnostic Criteria Indications for Treatment Prognostic Factors Treatment Response-adapted Therapy Relapsed/refractory Disease Novel Therapies Special Considerations Questions Answers Chapter 6: Non-Hodgkin Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Lymphoplasmacytic Lymphoma/waldenström Macroglobulinemia Chapter 7: High-Grade Non-Hodgkin Lymphoma Epidemiology Diagnostic Workup Staging and Special Considerations Treatment Diffuse Large B Cell Lymphoma Burkitt Lymphoma High Grade B-Cell Lymphoma Mantle Cell Lymphoma Primary Mediastinal B-cell Lymphoma Aids-related B-cell Lymphomas Posttransplant Lymphoproliferative Disorder (PTLD) Questions Answers Chapter 8: T-Cell Lymphoma Risk Factors Perpherial T-Cell Lymphoma Ptcl Pathology Ptcl Prognostic Factors Ptcl Treatment Rare T-Cell Leukemias/Lymphomas Questions Answers Chapter 9: Multiple Myeloma Epidemiology Etiology and Risk Factors Screening and Diagnostic Criteria Pathology Signs and Symptoms Risk Stratification Staging Treatment Questions Answers Part II: Aerodigestive Malignancies Chapter 10: Non–Small Cell Lung Cancer Etiology and Risk Factors Screening Prevention Pathology Signs and Symptoms Diagnostic Workup Staging Treatment Questions Answers Chapter 11: Small Cell Lung Cancer Background and Etiology Lung Cancer Screening Diagnosis Staging Treatment Limited Stage Extensive Stage Surveillance Other Clinical Pearls Questions Answers Chapter 12: Mesothelioma Epidemiology Etiology and Risk Factors Staging and Histological Classification Signs, Symptoms, and Imaging Findings Diagnosis Prognostic Factors Treatment Special Considerations Questions Answers Chapter 13: Thymoma Overview Etiology, Risk Factors, and Clinical Features Diagnosis Staging Classification Outcomes Treatment Questions Answers Chapter 14: Head and Neck Cancers Etiology and Risk Factors Staging Diagnostic Workup Treatment Location-Specific Considerations Questions Answers Part III: Endocrine Malignancies Chapter 15: Thyroid Cancers I. Thyroid Cancers II. Differentiated Thyroid Cancer III. Medullary Thyroid Cancer IV. Anaplastic Thyroid Cancer Chapter 16: Adrenal Cortical Carcinoma Epidemiology, Pathogenesis, and Risk Factors Staging Signs and Symptoms Diagnosis Treatment of Localized Disease Surveillance Treatment of Advanced Disease Questions Answers Chapter 17: Pheochromocytoma Epidemiology Etiology and Risk Factors Signs and Symptoms Diagnosis Treatment: Localized Disease Treatment: Metastatic Disease Prognosis and Surveillance Questions Answers Part IV: Breast Cancer Chapter 18: Breast Cancer Etiology and Risk Factors Staging Questions Answers Part V: Genitourinary Malignancies Chapter 19: Bladder Cancer Pathology/Cancer Genetics Staging Nonmuscle Invasive Bladder Cancer Muscle-Invasive Bladder Cancer Locally Advanced (Node-Positive)/Metastatic Bladder Cancer Questions Answers Chapter 20: Prostate Cancer Screening Pathology Signs and Symptoms Diagnosis Genetic Testing Staging Indications for Treatment Prognostic Factors Treatment Questions Answers Chapter 21: Testicular Cancer Pathology Diagnostic Workup Staging Prognostic Factors Treatment Special Considerations Questions Answers Chapter 22: Renal Cell Carcinoma Genetics Staging Signs and Symptoms Diagnostic Workup Prognostic Factors Treatment Questions Answers Part VI: Gastrointestinal Malignancies Chapter 23: Esophageal Cancer Etiology and Risk Factors Staging Signs and Symptoms Workup and Diagnosis Treatment—First Line Treatment—Recurrent Disease Treatment—Metastatic Disease Special Considerations Questions Answers Chapter 24: Gastric Cancer Epidemiology Etiology and Risk Factors Signs and Symptoms Staging Diagnosis Treatment Questions Answers Chapter 25: Colon Cancer Epidemiology Etiology and Risk Factors Screening Prevention Pathology Signs and Symptoms Diagnostic Workup Prognostic and Risk Factors Staging General Treatment Principles Colon Cancer Treatment by Stage Questions Answers Chapter 26: Anal Cancer Epidemiology Etiology and Risk Factors Screening and Prevention Pathology Signs and Symptoms Diagnostic Workup Staging General Principles of Treatment Treatment by Stage Questions Answers Chapter 27: Pancreatic and Biliary Cancers Epidemiology Risk Factors Staging Diagnostic Criteria Prognostic Factors Treatment Special Considerations Questions Answers Chapter 28: Hepatocellular Carcinoma Epidemiology Staging Signs and Symptoms Diagnostic Criteria Indications for Treatment Prognostic Factors Treatment Questions Answers Chapter 29: Neuroendocrine Tumors Epidemiology Pathology Signs and Symptoms Diagnostic Workup Treatment Questions Answers Part VII: Sarcoma Chapter 30: Sarcoma Closely Related to Sarcoma Genetics and Risk Factors Evaluation of Suspected Sarcoma Sts Staging Gist Staging Osteosarcoma Staging Treatment for Non-gist Soft Tissue Sarcoma Treatment for Bone Sarcomas Treatment for Gists Kaposi Sarcoma Questions Answers Part VIII: Melanoma Chapter 31: Melanoma Pathology Risk Factors Staging Diagnosis Prognostic Factors Treatment of Primary/Localized Melanoma Treatment of Metastatic Disease Questions Answers Part IX: Central Nervous System Malignancies Chapter 32: Central Nervous System Tumors General Part X: Gynecologic Malignancies Chapter 33: Cervical, Vulvar, and Vaginal Cancers Etiology, Risk Factors, and Histologic Subtypes Staging Treatment Special Considerations Questions Answers Chapter 34: Ovarian Cancer Pathology Etiology and Risk Factors Staging Management Questions Answers Chapter 35: Endometrial Cancer Epidemiology Etiology and Risk Factors Screening and Prevention Signs and Symptoms Staging Pathology Diagnostic Criteria Prognostic Factors Treatment Special Considerations Questions Answers Part XI: Cancer of Unknown Primary Chapter 36: Cancer of Unknown Primary Epidemiology Diagnosis Prognosis Treatment Questions Answers References Part XII: Genetics and Tumor Biology Chapter 37: Cancer Genetics Introduction Part XIII: Supportive and Palliative Care Chapter 38: Supportive Care Chemotherapy-induced Nausea and Vomiting Pain Management Constipation Cancer Cachexia Dyspnea Psychiatric Syndromes Questions Answers Part XIV: Bone Marrow Transplantation Chapter 39: Stem Cell Transplantation and Cellular Therapy Epidemiology Classification Eligibility Indications Toxicity of Conditioning Regimens Complications of Transplant Other Cellular Therapy (car-t) Questions Answers Part XV: Biostatistics Chapter 40: Biostatistics Example 40.1 Example 40.2 Example 40.3 Diagnostic Tests Clinical Study Design Biases Clinical Study Basics Questions Answers Index